These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1677 related articles for article (PubMed ID: 21296109)
1. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Scheller J; Chalaris A; Schmidt-Arras D; Rose-John S Biochim Biophys Acta; 2011 May; 1813(5):878-88. PubMed ID: 21296109 [TBL] [Abstract][Full Text] [Related]
2. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression. Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795 [TBL] [Abstract][Full Text] [Related]
3. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells. Kim H; Baumann H Mol Cell Biol; 1999 Aug; 19(8):5326-38. PubMed ID: 10409724 [TBL] [Abstract][Full Text] [Related]
4. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Rose-John S Int J Biol Sci; 2012; 8(9):1237-47. PubMed ID: 23136552 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-6: A Masterplayer in the Cytokine Network. Uciechowski P; Dempke WCM Oncology; 2020; 98(3):131-137. PubMed ID: 31958792 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 and its receptors: a highly regulated and dynamic system. Wolf J; Rose-John S; Garbers C Cytokine; 2014 Nov; 70(1):11-20. PubMed ID: 24986424 [TBL] [Abstract][Full Text] [Related]
7. Response to IL-6 trans- and IL-6 classic signalling is determined by the ratio of the IL-6 receptor α to gp130 expression: fusing experimental insights and dynamic modelling. Reeh H; Rudolph N; Billing U; Christen H; Streif S; Bullinger E; Schliemann-Bullinger M; Findeisen R; Schaper F; Huber HJ; Dittrich A Cell Commun Signal; 2019 May; 17(1):46. PubMed ID: 31101051 [TBL] [Abstract][Full Text] [Related]
8. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Mihara M; Hashizume M; Yoshida H; Suzuki M; Shiina M Clin Sci (Lond); 2012 Feb; 122(4):143-59. PubMed ID: 22029668 [TBL] [Abstract][Full Text] [Related]
9. TNF-alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex. Bode JG; Schweigart J; Kehrmann J; Ehlting C; Schaper F; Heinrich PC; Häussinger D J Immunol; 2003 Jul; 171(1):257-66. PubMed ID: 12817006 [TBL] [Abstract][Full Text] [Related]
10. The soluble interleukin-6 receptor and related proteins. Rose-John S Best Pract Res Clin Endocrinol Metab; 2015 Oct; 29(5):787-97. PubMed ID: 26522462 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. Rose-John S; Scheller J; Elson G; Jones SA J Leukoc Biol; 2006 Aug; 80(2):227-36. PubMed ID: 16707558 [TBL] [Abstract][Full Text] [Related]
12. Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex. Lacroix M; Rousseau F; Guilhot F; Malinge P; Magistrelli G; Herren S; Jones SA; Jones GW; Scheller J; Lissilaa R; Kosco-Vilbois M; Johnson Z; Buatois V; Ferlin W J Biol Chem; 2015 Nov; 290(45):26943-26953. PubMed ID: 26363066 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities. Scheller J; Garbers C; Rose-John S Semin Immunol; 2014 Feb; 26(1):2-12. PubMed ID: 24325804 [TBL] [Abstract][Full Text] [Related]
15. Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase. Giordano V; De Falco G; Chiari R; Quinto I; Pelicci PG; Bartholomew L; Delmastro P; Gadina M; Scala G J Immunol; 1997 May; 158(9):4097-103. PubMed ID: 9126968 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Heinrich PC; Behrmann I; Müller-Newen G; Schaper F; Graeve L Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):297-314. PubMed ID: 9716487 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 and its receptor: from bench to bedside. Scheller J; Rose-John S Med Microbiol Immunol; 2006 Dec; 195(4):173-83. PubMed ID: 16741736 [TBL] [Abstract][Full Text] [Related]
18. Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase. Takahashi-Tezuka M; Yoshida Y; Fukada T; Ohtani T; Yamanaka Y; Nishida K; Nakajima K; Hibi M; Hirano T Mol Cell Biol; 1998 Jul; 18(7):4109-17. PubMed ID: 9632795 [TBL] [Abstract][Full Text] [Related]
19. The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition. Garbers C; Aparicio-Siegmund S; Rose-John S Curr Opin Immunol; 2015 Jun; 34():75-82. PubMed ID: 25749511 [TBL] [Abstract][Full Text] [Related]
20. SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130. Lehmann U; Schmitz J; Weissenbach M; Sobota RM; Hortner M; Friederichs K; Behrmann I; Tsiaris W; Sasaki A; Schneider-Mergener J; Yoshimura A; Neel BG; Heinrich PC; Schaper F J Biol Chem; 2003 Jan; 278(1):661-71. PubMed ID: 12403768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]